Ask Questions About Clinical Trials
Part of paid clinical trials in Bay City, Michigan.
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Study ID
- NCT07343297
- Status
- Recruiting
Conditions
- Cardiac Disease
- Neurologic Disorder
- Oncology
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ask Questions about Clinical Trials brochure — BEHAVIORALCommunication intervention called a question prompt list
Study Details
The overall goal of this study is to assess the implementation of the Ask Questions about Clinical Trials (ASQ-CT) brochure, a patient-focused communication tool previously demonstrated to improve patient-provider communication about clinical trials. Participants will be given the ASQ-CT brochure at Time 1 (baseline) and participants will complete a questionnaire at three timepoints, baseline (Time 1), Pre-Research Visit (Time 2), and Post-Research Visit (Time 3).
Key Dates
- First listed
- Jan 15, 2026
- Start date
- Dec 30, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 30, 2027
- Completion
- Apr 5, 2028
Study Design
- Enrollment
- 293 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Ask Questions about Clinical Trials (ASQ-CT) BrochureAsk Questions about Clinical Trials (ASQ-CT), a clinical trial communication intervention brochure
Primary Outcome Measure
Effectiveness - Self-Efficacy in managing patient-provider interactions - Quantitative Scale [ Time Frame: From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2) ]
Central Contacts
- Lauren M Hamel, PhD, MBA1-800-527-6266
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Karmanos Cancer Institute at McLaren Bay Region | Bay City | Michigan | 48706 | 989-667-2370 |
| Karmanos Cancer Institute at McLaren Clarkston | Clarkston | Michigan | 48346 | 248-922-6650 |
| Karmanos Cancer Institute at McLaren Greater Lansing | Lansing | Michigan | 48910 | 517-975-9500 |
| Karmanos Cancer Institute at McLaren Lapeer | Lapeer | Michigan | 48446 | 810-667-4994 |
| Karmanos Cancer Institute at McLaren Macomb | Mount Clemens | Michigan | 48043 | 586-493-7510 |
| Karmanos Cancer Institute at McLaren Central Michigan, Morey Cancer Center | Mount Pleasant | Michigan | 48858 | 989-772-6811 |
| Karmanos Cancer Institute at McLaren Northern Michigan | Petoskey | Michigan | 49770 | 231-487-4209 |
| Karmanos Cancer Institute at McLaren Port Huron | Port Huron | Michigan | 48060 | 810-982-5200 |
Find similar trials in Bay City, MI
By research site
Karmanos Cancer Institute at McLaren Bay Region· Bay City, MIKarmanos Cancer Institute at McLaren Clarkston· Clarkston, MIKarmanos Cancer Institute at McLaren Greater Lansing· Lansing, MIKarmanos Cancer Institute at McLaren Lapeer· Lapeer, MIKarmanos Cancer Institute at McLaren Macomb· Mount Clemens, MIKarmanos Cancer Institute at McLaren Central Michigan, Morey Cancer Center· Mount Pleasant, MI
Related Studies
- RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic ChemotherapyPHASE2 · Recruiting · The Hospital for Sick Children · San Francisco, California
- Fresh Autologous Whole Blood Transfusion After Cardiopulmonary BypassRecruiting · University of Colorado, Denver · Aurora, Colorado
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania
- Autoimmunity After Checkpoint BlockadeRecruiting · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania